Skip to main content
Log in

Uncommon Peptide Bond Cleavage of Glucagon from a Specific Vendor under near Neutral to Basic Conditions

  • Research Paper
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose

The main purposes of this manuscript are to report a surprising and interesting degradation reaction of glucagon from a specific vendor in which glucagon underwent cleavage among several peptide bonds quickly under near neutral to basic conditions, and to propose the root cause of mechanism for the degradation reaction.

Methods

The degradation reaction was monitored by HPLC and the fragment structures were confirmed by LC-MS. Possible impurities responsible for the degradation were either confirmed or excluded by a variety of techniques such as addition of chelator EDTA and transitional metal ions or separation by ultrafiltration.

Results

This type of degradation was rarely reported in literature, especially considering its extreme cleavage efficiency. Contamination by a thermostable high molecular impurity (such as a peptidase with molecular weight between 10 and 30 KDa) during the manufacturing process was the main reason for this interesting phenomenon.

Conclusions

The degradation phenomenon described here could be used as an excellent example showing that products ordered from vendors meeting the rudimentary quality standards might contain impurities which could cause significant degradation. We suggest that a simple solution, i.e. additional tests of stability under real or accelerated conditions by manufacturers and inclusion of the “accelerated stability criteria” in the Certificate of Analysis (CoAs), especially for sensitive biological reagents prone to faster degradation, would be very helpful for avoiding losses for both vendors and users.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14

Similar content being viewed by others

Abbreviations

Amino acid:

Were abbreviated according to the rules of the IUPAC-IUB Joint Commission of Biochemical Nomenclature (Eur. J. Biochem. 1984, 138, 9–37)

EDTA:

Ethylenediaminetetraacetic acid

LC-MS:

Liquid chromatography-mass spectrometry

MALDI-TOF MS:

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

RP-HPLC:

Reversed-phase high-performance liquid chromatography

tR :

Retention time

References

  1. Granner D, Pilkis S. The genes of hepatic glucose metabolism. J Biol Chem. 1990;265:10173–6.

    CAS  PubMed  Google Scholar 

  2. Joshi AB, Rus E, Kirsch LE. The degradation pathways of glucagon in acidic solutions. Int J Pharm. 2000;203:115–25.

    Article  CAS  Google Scholar 

  3. Joshi AB, Kirsch LE. The relative rates of glutamine and asparagine deamidation in glucagon fragment 22-29 under acidic conditions. J Pharm Sci. 2002;91:2331–45.

    Article  Google Scholar 

  4. Joshi AB, Kirsch LE. The estimation of glutaminyl deamidation and aspartyl cleavage rates in glucagon. Int J Pharm. 2004;273:213–9.

    Article  CAS  Google Scholar 

  5. Joshi AB, Sawai M, Kearney WR, Kirsch LE. Studies on the mechanism of aspartic acid cleavage and glutamine deamidation in the acidic degradation of glucagon. J Pharm Sci. 2005;94:1912–27.

    Article  CAS  Google Scholar 

  6. Caputo N, Castle JR, Bergstrom CP, Carroll JM, Bakhtiani PA, Jackson MA, et al. Mechanisms of glucagon degradation at alkaline pH. Peptides. 2013;45:40–7.

    Article  CAS  Google Scholar 

  7. Fang W-J, Qi W, Kinzell J, Prestrelski S, Carpenter JF. Effects of excipients on the chemical and physical stability of glucagon during freeze-drying and storage in dried formulations. Pharm Res. 2012;29:3278–91.

    Article  CAS  Google Scholar 

  8. Ghodke S, Nielsen SB, Christiansen G, Hjuler HA, Flink J, Otzen D. Mapping out the multistage fibrillation of glucagon. FEBS J. 2012;279:752–65.

    Article  CAS  Google Scholar 

  9. Moorthy BS, Ghomi HT, Lill MA, Topp EM. Structural transitions and interactions in the early stages of human glucagon amyloid fibrillation. Biophys J. 2015;108:937–48.

    Article  CAS  Google Scholar 

  10. Pedersen JS, Dikov D, Otzen DE. N- and C-terminal hydrophobic patches are involved in fibrillation of glucagon. Biochemistry. 2006;45:14503–12.

    Article  Google Scholar 

  11. Smith MA, Easton M, Everett P, Lewis G, Payne M, Riveros-Moreno V, et al. Specific cleavage of immunoglobulin G by copper ions. Int J Pept Protein Res. 1996;48:48–55.

    Article  CAS  Google Scholar 

  12. Glover ZK, Basa L, Moore B, Laurence JS, Sreedhara A. Metal ion interactions with mAbs: part 1. mAbs. 2015;7:901–11.

    Article  CAS  Google Scholar 

  13. Chin J. Developing artificial hydrolytic metalloenzymes by a unified mechanistic approach. Acc Chem Res. 1991;24:145–52.

    Article  CAS  Google Scholar 

  14. Smith MA, Easton M, Everett P, Lewis G, Payne M. Specific cleavage of immunoglobulin G by copper ions. Int J Pept Protein Res. 1996;48:48–55.

    Article  CAS  Google Scholar 

  15. Vlasak J, Ionescu R. Fragmentation of monoclonal antibodies. mAbs. 2011;3:253–63.

    Article  Google Scholar 

  16. Gaza-Bulseco G, Liu H. Fragmentation of a recombinant monoclonal antibody at various pH. Pharm Res. 2008;25:1881–90.

    Article  CAS  Google Scholar 

  17. Liu H, Gaza-Bulseco G, Sun J. Characterization of the stability of a fully human monoclonal IgG after prolonged incubation at elevated temperature. J Chromatogr B Analyt Technol Biomed Life Sci. 2006;837:35–43.

    Article  CAS  Google Scholar 

  18. Kamerzell TJ, Li M, Arora S, Ji JA, Wang YJ. The relative rate of immunoglobulin gamma 1 fragmentation. J Pharm Sci. 2011;100:1341–9.

    Article  CAS  Google Scholar 

  19. Ravuluri S, Bansal R, Chhabra N, Rathore AS. Kinetics and characterization of non-enzymatic fragmentation of monoclonal antibody therapeutics. Pharm Res. 2018;35:142.

    Article  Google Scholar 

  20. Gao SX, Zhang Y, Stansberry-Perkins K, Buko A, Bai S, Nguyen V, et al. Fragmentation of a highly purified monoclonal antibody attributed to residual CHO cell protease activity. Biotechnol Bioeng. 2011;108:977–82.

    Article  CAS  Google Scholar 

Download references

Acknowledgments and Disclosures

We thank the Ministry of Science and Technology of China (Grant No. 2018ZX09J18107–002), National Natural Science Foundation of China (Grant No. 81741144), and the Fundamental Research Funds for the Central Universities (Grant No. 2019XZZX003–18) for their financial support. We would also like to extend our thanks to Zhiwei Ge and Youping Xu at the Analysis Center of Agrobiology and Environmental Sciences, Zhejiang University for their help on LC-MS and MALDI-TOF MS analysis, respectively. We have no personal financial or non-financial conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wei-Jie Fang.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zheng, HJ., Shen, BB., Wang, J. et al. Uncommon Peptide Bond Cleavage of Glucagon from a Specific Vendor under near Neutral to Basic Conditions. Pharm Res 36, 118 (2019). https://doi.org/10.1007/s11095-019-2647-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11095-019-2647-y

Keywords

Navigation